Global Small Interfering RNA (siRNA) Therapeutics Market Size, Share, and COVID-19 Impact Analysis, By Delivery (Lipid Nanoparticles (LNPs), Conjugates), By Indication (Hereditary Transthyretin-mediated Amyloidosis, Acute Hepatic Porphyria, Primary Hyperoxaluria Type 1, Primary Hypercholesterolemia, Others), By RoA (Intravenous (IV), Subcutaneous), and By Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 - 2033

Industry: Healthcare
RELEASE DATE Oct 2024
REPORT ID SI7003
PAGES 245
REPORT FORMAT PathSoft
Request Free Sample
Description Table of Contents Scope of Report Methodology
  1. Introduction
    1. Objectives of the Study
    2. Market Definition
    3. Research Scope
  2. Research Methodology and Assumptions
  3. Executive Summary
  4. Premium Insights
    1. Porter’s Five Forces Analysis
    2. Value Chain Analysis
    3. Top Investment Pockets
      1. Market Attractiveness Analysis, By Delivery
      2. Market Attractiveness Analysis, By Indication
      3. Market Attractiveness Analysis, By RoA
      4. Market Attractiveness Analysis, By Region
    4. Industry Trends
  5. Market Dynamics
    1. Market Evaluation
    2. Drivers
      1. Advances in RNA delivery methods, and increased funding for RNA-based drug development
    3. Restraints
      1.  High development costs
    4. Opportunities
      1.  The rising prevalence of genetic illnesses and the demand for precision medicine
    5. Challenges
      1. Low knowledge of RNA-based medicines further hamper market expansion
  6. Global Small Interfering RNA (siRNA) Therapeutics Market Analysis and Projection, By Delivery
    1. Segment Overview
    2. Lipid Nanoparticles (LNPs)
    3. Conjugates
  7. Global Small Interfering RNA (siRNA) Therapeutics Market Analysis and Projection, By Indication
    1. Segment Overview
    2. Hereditary Transthyretin-mediated Amyloidosis
    3. Acute Hepatic Porphyria
    4. Primary Hyperoxaluria Type 1
    5. Primary Hypercholesterolemia
    6. Others
  8. Global Small Interfering RNA (siRNA) Therapeutics Market Analysis and Projection, By RoA
    1. Segment Overview
    2. Intravenous (IV)
    3. Subcutaneous
  9. Global Small Interfering RNA (siRNA) Therapeutics Market Analysis and Projection, By Regional Analysis
    1. Segment Overview
    2. North America
      1. U.S.
      2. Canada
      3. Mexico
    3. Europe
      1. Germany
      2. France
      3. U.K.
      4. Italy
      5. Spain
    4. Asia-Pacific
      1. Japan
      2. China
      3. India
    5. South America
      1. Brazil
    6. Middle East and Africa
      1. UAE
      2. South Africa
  10. Global Small Interfering RNA (siRNA) Therapeutics Market-Competitive Landscape
    1. Overview
    2. Market Share of Key Players in the Small Interfering RNA (siRNA) Therapeutics Market
      1. Global Company Market Share
      2. North America Company Market Share
      3. Europe Company Market Share
      4. APAC Company Market Share
    3. Competitive Situations and Trends
      1. Coverage Launches and Developments
      2. Partnerships, Collaborations, and Agreements
      3. Mergers & Acquisitions
      4. Expansions
  11. Company Profiles
    1. Alnylam
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    2.   Quark Pharmaceuticals 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    3.  Dicerna Pharmaceuticals
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    4.   Arrowhead Pharmaceuticals
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    5.   Novartis
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    6.  Novo Nordisk
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    7.   Johnson & Johnson company
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    8. GSK
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    9.  Silence Therapeutics
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    10.  Silenseed Ltd
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    11.  Sylentis, S.A.
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    12.   Sanofi Genzyme
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    13.  Aro Biotherapeutics
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    14.  Others
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis

List of Table

  1. Global Small Interfering RNA (siRNA) Therapeutics Market, By Delivery, 2023-2033(USD Billion)
  2. Global Lipid Nanoparticles (LNPs), Small Interfering RNA (siRNA) Therapeutics Market, By Region, 2023-2033(USD Billion)
  3. Global Conjugates, Small Interfering RNA (siRNA) Therapeutics Market, By Region, 2023-2033(USD Billion)
  4. Global Small Interfering RNA (siRNA) Therapeutics Market, By Indication, 2023-2033(USD Billion)
  5. Global Hereditary Transthyretin-mediated Amyloidosis, Small Interfering RNA (siRNA) Therapeutics Market, By Region, 2023-2033(USD Billion)
  6. Global Acute Hepatic Porphyria, Small Interfering RNA (siRNA) Therapeutics Market, By Region, 2023-2033(USD Billion)
  7. Global Primary Hyperoxaluria Type 1, Small Interfering RNA (siRNA) Therapeutics Market, By Region, 2023-2033(USD Billion)
  8. Global Primary Hypercholesterolemia, Small Interfering RNA (siRNA) Therapeutics Market, By Region, 2023-2033(USD Billion)
  9. Global Others, Small Interfering RNA (siRNA) Therapeutics Market, By Region, 2023-2033(USD Billion)
  10. Global Small Interfering RNA (siRNA) Therapeutics Market, By RoA, 2023-2033(USD Billion)
  11. Global Intravenous (IV), Small Interfering RNA (siRNA) Therapeutics Market, By Region, 2023-2033(USD Billion)
  12. Global Subcutaneous, Small Interfering RNA (siRNA) Therapeutics Market, By Region, 2023-2033(USD Billion)
  13. North America Small Interfering RNA (siRNA) Therapeutics Market, By Delivery, 2023-2033(USD Billion)
  14. North America Small Interfering RNA (siRNA) Therapeutics Market, By Indication, 2023-2033(USD Billion)
  15. North America Small Interfering RNA (siRNA) Therapeutics Market, By RoA, 2023-2033(USD Billion)
  16. U.S.  Small Interfering RNA (siRNA) Therapeutics Market, By Delivery, 2023-2033(USD Billion)
  17. U.S.  Small Interfering RNA (siRNA) Therapeutics Market, By Indication, 2023-2033(USD Billion)
  18. U.S.  Small Interfering RNA (siRNA) Therapeutics Market, By RoA, 2023-2033(USD Billion)
  19. Canada Small Interfering RNA (siRNA) Therapeutics Market, By Delivery, 2023-2033(USD Billion)
  20. Canada Small Interfering RNA (siRNA) Therapeutics Market, By Indication, 2023-2033(USD Billion)
  21. Canada Small Interfering RNA (siRNA) Therapeutics Market, By RoA, 2023-2033(USD Billion)
  22. Mexico Small Interfering RNA (siRNA) Therapeutics Market, By Delivery, 2023-2033(USD Billion)
  23. Mexico Small Interfering RNA (siRNA) Therapeutics Market, By Indication, 2023-2033(USD Billion)
  24. Mexico Small Interfering RNA (siRNA) Therapeutics Market, By RoA, 2023-2033(USD Billion)
  25. Europe Small Interfering RNA (siRNA) Therapeutics Market, By Delivery, 2023-2033(USD Billion)
  26. Europe Small Interfering RNA (siRNA) Therapeutics Market, By Indication, 2023-2033(USD Billion)
  27. Europe Small Interfering RNA (siRNA) Therapeutics Market, By RoA, 2023-2033(USD Billion)
  28. Germany Small Interfering RNA (siRNA) Therapeutics Market, By Delivery, 2023-2033(USD Billion)
  29. Germany Small Interfering RNA (siRNA) Therapeutics Market, By Indication, 2023-2033(USD Billion)
  30. Germany Small Interfering RNA (siRNA) Therapeutics Market, By RoA, 2023-2033(USD Billion)
  31. France Small Interfering RNA (siRNA) Therapeutics Market, By Delivery, 2023-2033(USD Billion)
  32. France Small Interfering RNA (siRNA) Therapeutics Market, By Indication, 2023-2033(USD Billion)
  33. France Small Interfering RNA (siRNA) Therapeutics Market, By RoA, 2023-2033(USD Billion)
  34. U.K.  Small Interfering RNA (siRNA) Therapeutics Market, By Delivery, 2023-2033(USD Billion)
  35. U.K.  Small Interfering RNA (siRNA) Therapeutics Market, By Indication, 2023-2033(USD Billion)
  36. U.K.  Small Interfering RNA (siRNA) Therapeutics Market, By RoA, 2023-2033(USD Billion)
  37. Italy Small Interfering RNA (siRNA) Therapeutics Market, By Delivery, 2023-2033(USD Billion)
  38. Italy Small Interfering RNA (siRNA) Therapeutics Market, By Indication, 2023-2033(USD Billion)
  39. Italy Small Interfering RNA (siRNA) Therapeutics Market, By RoA, 2023-2033(USD Billion)
  40. Spain Small Interfering RNA (siRNA) Therapeutics Market, By Delivery, 2023-2033(USD Billion)
  41. Spain Small Interfering RNA (siRNA) Therapeutics Market, By Indication, 2023-2033(USD Billion)
  42. Spain Small Interfering RNA (siRNA) Therapeutics Market, By RoA, 2023-2033(USD Billion)
  43. Asia Pacific Small Interfering RNA (siRNA) Therapeutics Market, By Delivery, 2023-2033(USD Billion)
  44. Asia Pacific Small Interfering RNA (siRNA) Therapeutics Market, By Indication, 2023-2033(USD Billion)
  45. Asia Pacific Small Interfering RNA (siRNA) Therapeutics Market, By RoA, 2023-2033(USD Billion)
  46. Japan Small Interfering RNA (siRNA) Therapeutics Market, By Delivery, 2023-2033(USD Billion)
  47. Japan Small Interfering RNA (siRNA) Therapeutics Market, By Indication, 2023-2033(USD Billion)
  48. Japan Small Interfering RNA (siRNA) Therapeutics Market, By RoA, 2023-2033(USD Billion)
  49. China Small Interfering RNA (siRNA) Therapeutics Market, By Delivery, 2023-2033(USD Billion)
  50. China Small Interfering RNA (siRNA) Therapeutics Market, By Indication, 2023-2033(USD Billion)
  51. China Small Interfering RNA (siRNA) Therapeutics Market, By RoA, 2023-2033(USD Billion)
  52. India Small Interfering RNA (siRNA) Therapeutics Market, By Delivery, 2023-2033(USD Billion)
  53. India Small Interfering RNA (siRNA) Therapeutics Market, By Indication, 2023-2033(USD Billion)
  54. India Small Interfering RNA (siRNA) Therapeutics Market, By RoA, 2023-2033(USD Billion)
  55. South America Small Interfering RNA (siRNA) Therapeutics Market, By Delivery, 2023-2033(USD Billion)
  56. South America Small Interfering RNA (siRNA) Therapeutics Market, By Indication, 2023-2033(USD Billion)
  57. South America Small Interfering RNA (siRNA) Therapeutics Market, By RoA, 2023-2033(USD Billion)
  58. Brazil Small Interfering RNA (siRNA) Therapeutics Market, By Delivery, 2023-2033(USD Billion)
  59. Brazil Small Interfering RNA (siRNA) Therapeutics Market, By Indication, 2023-2033(USD Billion)
  60. Brazil Small Interfering RNA (siRNA) Therapeutics Market, By RoA, 2023-2033(USD Billion)
  61. The Middle East and Africa Small Interfering RNA (siRNA) Therapeutics Market, By Delivery, 2023-2033(USD   Billion)
  62. The Middle East and Africa Small Interfering RNA (siRNA) Therapeutics Market, By Indication, 2023-2033(USD   Billion)
  63. The Middle East and Africa Small Interfering RNA (siRNA) Therapeutics Market, By RoA, 2023-2033(USD Billion)
  64. UAE Small Interfering RNA (siRNA) Therapeutics Market, By Delivery, 2023-2033(USD Billion)
  65. UAE Small Interfering RNA (siRNA) Therapeutics Market, By Indication, 2023-2033(USD Billion)
  66. UAE Small Interfering RNA (siRNA) Therapeutics Market, By RoA, 2023-2033(USD Billion) 
  67. South Africa Small Interfering RNA (siRNA) Therapeutics Market, By Delivery, 2023-2033(USD Billion)
  68. South Africa Small Interfering RNA (siRNA) Therapeutics Market, By Indication, 2023-2033(USD Billion)
  69. South Africa Small Interfering RNA (siRNA) Therapeutics Market, By RoA, 2023-2033(USD Billion)

List of Figures 

  1. Global Small Interfering RNA (siRNA) Therapeutics Market Segmentation
  2. Small Interfering RNA (siRNA) Therapeutics Market: Research Methodology
  3. Market Size Estimation Methodology: Bottom-Up Approach
  4. Market Size Estimation Methodology: Top-down Approach
  5. Data Triangulation
  6. Porter’s Five Forces Analysis
  7. Value Chain Analysis
  8. Top investment pocket in the Small Interfering RNA (siRNA) Therapeutics Market
  9. Top Winning Strategies, 2023-2033
  10. Top Winning Strategies, By Development, 2023-2033(%)
  11. Top Winning Strategies, By Company, 2023-2033
  12. Moderate Bargaining power of Buyers
  13. Moderate Bargaining power of Suppliers
  14. Moderate Bargaining power of New Entrants
  15. Low threat of Substitution
  16. High Competitive Rivalry
  17. Top Player Positioning, 2023
  18. Market Share Analysis, 2023
  19. Restraint and Drivers:  Small Interfering RNA (siRNA) Therapeutics Market
  20. Small Interfering RNA (siRNA) Therapeutics Market Segmentation, By Delivery
  21. Small Interfering RNA (siRNA) Therapeutics Market For Lipid Nanoparticles (LNPs), By Region, 2023-2033 ($ Billion)
  22.  Small Interfering RNA (siRNA) Therapeutics Market For Conjugates, By Region, 2023-2033 ($ Billion)
  23.  Small Interfering RNA (siRNA) Therapeutics Market Segmentation, By Indication
  24.  Small Interfering RNA (siRNA) Therapeutics Market For Hereditary Transthyretin-mediated Amyloidosis, By Region, 2023-2033 ($ Billion)
  25.  Small Interfering RNA (siRNA) Therapeutics Market For Acute Hepatic Porphyria, By Region, 2023-2033 ($ Billion)
  26. Small Interfering RNA (siRNA) Therapeutics Market For Primary Hyperoxaluria Type 1, By Region, 2023-2033 ($ Billion)
  27. Small Interfering RNA (siRNA) Therapeutics Market For Primary Hypercholesterolemia, By Region, 2023-2033 ($ Billion)
  28. Small Interfering RNA (siRNA) Therapeutics Market For Others, By Region, 2023-2033 ($ Billion)
  29. Small Interfering RNA (siRNA) Therapeutics Market Segmentation, By RoA
  30. Small Interfering RNA (siRNA) Therapeutics Market For Intravenous (IV), By Region, 2023-2033 ($ Billion)
  31. Small Interfering RNA (siRNA) Therapeutics Market For Subcutaneous, By Region, 2023-2033 ($ Billion)
  32. Alnylam: Net Sales, 2023-2033 ($ Billion)
  33. Alnylam: Revenue Share, By Segment, 2023 (%)
  34. Alnylam: Revenue Share, By Region, 2023 (%)
  35. Quark Pharmaceuticals: Net Sales, 2023-2033 ($ Billion)
  36. Quark Pharmaceuticals: Revenue Share, By Segment, 2023 (%)
  37. Quark Pharmaceuticals: Revenue Share, By Region, 2023 (%)
  38. Dicerna Pharmaceuticals: Net Sales, 2023-2033 ($ Billion)
  39. Dicerna Pharmaceuticals: Revenue Share, By Segment, 2023 (%)
  40. Dicerna Pharmaceuticals: Revenue Share, By Region, 2023 (%)
  41. Arrowhead Pharmaceuticals: Net Sales, 2023-2033 ($ Billion)
  42. Arrowhead Pharmaceuticals: Revenue Share, By Segment, 2023 (%)
  43. Arrowhead Pharmaceuticals: Revenue Share, By Region, 2023 (%)
  44. Novartis: Net Sales, 2023-2033 ($ Billion)
  45. Novartis: Revenue Share, By Segment, 2023 (%)
  46. Novartis: Revenue Share, By Region, 2023 (%)
  47. Novo Nordisk: Net Sales, 2023-2033 ($ Billion)
  48. Novo Nordisk: Revenue Share, By Segment, 2023 (%)
  49. Novo Nordisk: Revenue Share, By Region, 2023 (%)
  50. Johnson & Johnson company: Net Sales, 2023-2033 ($ Billion)
  51. Johnson & Johnson company: Revenue Share, By Segment, 2023 (%)
  52. Johnson & Johnson company: Revenue Share, By Region, 2023 (%)
  53. GSK: Net Sales, 2023-2033 ($ Billion)
  54. GSK: Revenue Share, By Segment, 2023 (%)
  55. GSK: Revenue Share, By Region, 2023 (%)
  56. Silence Therapeutics.: Net Sales, 2023-2033 ($ Billion)
  57. Silence Therapeutics.: Revenue Share, By Segment, 2023 (%)
  58. Silence Therapeutics.: Revenue Share, By Region, 2023 (%)
  59. Silenseed Ltd: Net Sales, 2023-2033 ($ Billion)
  60. Silenseed Ltd: Revenue Share, By Segment, 2023 (%)
  61. Silenseed Ltd: Revenue Share, By Region, 2023 (%)
  62. Sylentis, S.A.: Net Sales, 2023-2033 ($ Billion)
  63. Sylentis, S.A.: Revenue Share, By Segment, 2023 (%)
  64. Sylentis, S.A.: Revenue Share, By Region, 2023 (%)
  65. Sanofi Genzyme: Net Sales, 2023-2033 ($ Billion)
  66. Sanofi Genzyme: Revenue Share, By Segment, 2023 (%)
  67. Sanofi Genzyme: Revenue Share, By Region, 2023 (%)
  68. Aro Biotherapeutics: Net Sales, 2023-2033 ($ Billion)
  69. Aro Biotherapeutics: Revenue Share, By Segment, 2023 (%)
  70. Aro Biotherapeutics: Revenue Share, By Region, 2023 (%)
  71. Others: Net Sales, 2023-2033 ($ Billion)
  72. Others: Revenue Share, By Segment, 2023 (%)
  73. Others: Revenue Share, By Region, 2023 (%)

 

Buy Now

  • Access to only 1 person; cannot be shared; cannot be printed
  • Access for 2 to 5 users only within same department of one company
  • Access to a company wide audience; includes subsidiary companies or other companies within a group of companies

Premium Report Details

Base Year:2023
Tables & Figures:110
Pages:245
Countries covered:17
Companies covered::20
Forecast CAGR:14.37%
Request Discount

15% Free Customization

Share your Requirements

Request Customization

We Covered in Market

  • 24/7 Analyst Support
  • Worldwide Clients
  • Tailored Insights
  • Technology Evolution
  • Competitive Intelligence
  • Custom Research
  • Syndicated Market Research
  • Market Snapshot
  • Market Segmentation
  • Growth Dynamics
  • Market Opportunities
  • Regulatory Overview
  • Innovation & Sustainability

Connect with us

Need help to buy this report?

Inquiry Before Buy
We'll use cookies to improve and customize your experience if you continue to browse. Is it OK if we also use cookies to show you personalized ads?
Learn more and manage your cookies
Yes, Accept Cookies